Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

1.16
BATS BZX Real-Time Price
As of 12:00pm ET
 -0.005 / -0.43%
Today’s Change
1.13
Today|||52-Week Range
4.62
-58.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues28.1M61.2M0.000.00
 
 
 
Cost of Goods Sold1.0M3.3M0.000.00
 
 
 
Depreciation And Amortization2.2M1.0M1.2M876.0K
 
 
 
 
 
 
Operating ExpensesGross Income24.9M56.9M-1.2M-876.0K
 
 
 
 
 
General Expenses47.9M75.3M26.1M33.7M
 
 
 
 
 
Research And Development32.1M52.2M21.6M19.8M
 
 
 
 
 
Total Operating Expenses51.1M79.7M27.2M34.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.1M-18.4M-27.2M-34.5M
 
 
 
 
 
Extraordinary Charge-15.4M-7.8M0.000.00
 
 
 
Interest Expense On Debt0.007.1M2.0M26.8M
 
 
 
 
Other Expenses385.0K-286.0K-2.0K1.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-30.3M-33.6M-29.2M-59.9M
 
 
 
 
 
Income Taxes0.000.000.00-30.2M
 
 
Minority Interest-207.0K-1.2M-467.0K-724.0K
 
 
 
 
 
Discontinued Operations0.000.00-947.0K-57.6M
 
 
 
Extraordinary Items0.000.000.00598.1M
 
 
Net Income-30.1M-32.4M-29.7M-86.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS129.2M129.8M130.6M132.5M
 
 
 
 
 
Shares To Calculate EPS Diluted129.2M129.8M130.6M132.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.23-$0.25-$0.23$3.86
 
 
 
 
 
EPS Diluted-$0.23-$0.25-$0.23-$0.65